A carregar...
COX2 genetic variation, NSAIDs, and advanced prostate cancer risk
Collective evidence suggests that cyclooxygenase 2 (COX2) plays a role in prostate cancer risk. Cyclooxygenase 2 is the major enzyme that converts arachidonic acid to prostaglandins, which are potent mediators of inflammation. Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit the enzymatic activ...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2360347/ https://ncbi.nlm.nih.gov/pubmed/17609663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603874 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|